Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis

Completed · Phase 2

Conditions studied: Uveitis, Anterior

In brief

The purpose of this study is to define a safe and effective dose of iontophoretic delivery of dexamethasone phosphate ophthalmic solution using the EyeGate® II Drug Delivery System in patients with non-infectious anterior segment uveitis.

Key facts

Study ID
NCT00694135
Run by
Eyegate Pharmaceuticals, Inc.
People needed
40
Starts
2008-06-01
Expected to finish
2009-08-01
Last updated by the study team
2010-08-31

Who can join

Age: 12 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.